No Detail Found!

Frequency of thrombocytopenia in chronic active hepatitis c patients – A hindrance in treatment.

Author(s)
M. Aziz Department of Haematology, Shaikh Zayed Hospital, Lahore, Pakistan
S. Khan Department of Haematology, Shaikh Zayed Hospital, Lahore, Pakistan
Abstract
Background: Hepatitis C virus (HCV) is considered to be the main etiological factor for chronic liver disease. Thrombocytopenia is a common complication in patients with chronic liver disease which has been observed in 76% of cases. This occurs due to splenic platelet sequestration, bone marrow suppression by chronic hepatitis C and antiviral therapy. Objective: The present study was designed to determine the frequency of Thrombocytopenia in Chronic Active Hepatitis (CAH) caused by Hepatitis C virus (HCV). Study design: It was a Cross Sectional study. Place and duration of study: This study was conducted in Department of Hematology, Shaikh Zayed Hospital Lahore from June to December 2010. Results: In the present study the frequency of thrombocytopenia was 22.6%. Conclusion: Patients who develop hematological abnormalities during treatment need hematological growth factor support so that treatment should be continued with no hindrance.
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Biomedica, Volume: 30, Issue: 3, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

78

Views